Sex Discrepancy May Explain Lower OS in Women With Advanced Bladder Cancer

Share this content:
Poor OS in women with bladder cancer may be attributable to the lower frequency of women being treated with systemic chemotherapy.
Poor OS in women with bladder cancer may be attributable to the lower frequency of women being treated with systemic chemotherapy.

Poor overall survival (OS) in women with advanced bladder cancer, as compared with men with the same disease, may be attributable to the lower frequency of women being treated with systemic chemotherapy, authors of an article in Cancer stated.1

Researchers led by Tracy L. Rose, MD, MPH, of the University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, identified 23,981 patients diagnosed with stage IV bladder cancer between 1998 and 2010, 35% of whom were female.  Adjusting for the gendered-based difference in likelihood of receiving systemic chemotherapy, the authors found that OS was lower for women than men (hazard ratio for death, 1.11 [95% CI, 1.08-1.15]).

It was concluded that although men with advanced bladder cancer are 7% more likely to be treated with systemic chemotherapy, other unidentified factors, such as unmeasured comorbidities and tumor biology may account for lower OS in women.

RELATED: Bladder Cancer Risk Higher Following Prostate Radiotherapy

Prior to adjustment, OS was an average of 1.8 months lower for women (8.0 months [95% CI, 7.7-8.3]), than for men (9.8 months [95% CI, 9.5-10.0]), where P < .001. There was no difference in comorbidity score between the 2 groups; women in the cohort, however, were more likely to be older, less likely to be insured, and were more often African-American.

Reference

  1. Rose TL, Deal AM, Nielsen ME, Smith AB, Milowsky MI. Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer [published online ahead of print May 25, 2016]. Cancer. doi: 10.1002/cncr.30029.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs